Detalhe da pesquisa
1.
Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study.
Int J Clin Oncol;
29(2): 188-194, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37991558
2.
FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study.
BMC Cancer;
23(1): 177, 2023 Feb 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36809997
3.
Nal-IRI/5-FU/LV versus modified FOLFIRINOX and FOLFIRI as second-line chemotherapy for unresectable pancreatic cancer: A single center retrospective study.
Pancreatology;
22(6): 789-796, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35705458
4.
Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancer.
Cancer Sci;
112(11): 4679-4691, 2021 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34382298
5.
Association between time to stent dysfunction and the anti-tumour effect of systemic chemotherapy following stent placement in patients with pancreaticobiliary cancers and malignant gastric outlet obstruction: a retrospective cohort study.
BMC Cancer;
21(1): 576, 2021 May 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34011301
6.
Repeated Lusutrombopag Treatment for Thrombocytopenia in Patients with Chronic Liver Disease.
Digestion;
102(4): 654-662, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32841939
7.
Sarcopenia: Prognostic Value for Unresectable Pancreatic Ductal Adenocarcinoma Patients Treated With Gemcitabine Plus Nab-Paclitaxel.
Pancreas;
51(2): 148-152, 2022 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35404889
8.
Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as a second-line treatment regimen for unresectable pancreatic cancer: A real-world analysis.
Cancer Med;
11(4): 1088-1098, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34953056
9.
Repeated transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres vs. conventional transarterial chemoembolization for hepatocellular carcinoma.
Mol Clin Oncol;
14(6): 119, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33903825